Skip to main content

Understand Your European Market Access Barriers

Identify reimbursement, payer and HTA barriers and define practical next steps.

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Italy's 2027 Budget Draft Proposes Higher Healthcare Funding and Changes to Medical-Device Spending and Payback Rules

The Italian National Health Service (Servizio Sanitario Nazionale, SSN) is primarily financed through public taxation, with resources allocated to regions responsible for organizing, purchasing, and delivering healthcare services. 

On October 28, 2026, the Council of Ministers approved the draft Budget Law for 2027 and the multi-year budget covering 2027-2029.

The proposed healthcare measures include the following key changes:

Increased National Health Service funding 

  • SSN funding is proposed to increase to approximately €146 billion in 2027, providing additional resources for the national healthcare system.

Additional funding for hospital tariff revisions

  • The draft earmarks €500 million annually for updating maximum national reimbursement tariffs for acute inpatient and day-case hospital services.

Higher medical-device expenditure ceiling

  • The national medical-device expenditure ceiling is proposed to increase from 4.6% to 4.7% of SSN funding from 2027. Based on the proposed 2027 funding level, this corresponds to approximately €146 million in additional annual spending capacity.

Partial state contribution towards medical-device payback liabilities

  • The draft proposes a state contribution of €350 million annually from 2028 to 2031, amounting to €1.4 billion in total, towards medical-device payback liabilities relating to 2019–2023. 
  • The remaining estimated €2.6 billion would continue to be borne by medical-device suppliers, with payments scheduled between 2027 and 2031.

The Budget Law remains subject to parliamentary approval. Further implementing measures may be required, particularly for hospital tariff revisions and medical-device payback arrangements.

What does it mean for the industry?

The proposed Budget Law combines increased healthcare funding and a higher medical-device expenditure ceiling with partial state support for historical payback liabilities. While the increase in the expenditure ceiling provides additional spending capacity for medical devices, the proposed state contribution would cover only part of the outstanding payback burden, leaving an estimated €2.6 billion payable by suppliers.

This news is just one of about 300 market access news and updates collected by our team in the premium subscription service MTRC Access Intelligence every week from more than 80 organizations. Access our paid service to stay on top of all developments, specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, six-week, no-obligation trial.